Skip to main content

Table 1 Baseline characteristics of the enrolled patients in all groups

From: Zero-fluoroscopy approach for ablation of supraventricular tachycardia using the Ensite NavX system: a multicenter experience

 

ZF (n = 1020)

CF (n = 2040)

Total cohort (n = 3060)

Mean age (years)

45.4 ± 15.4

45.2 ± 15.3

45.3 ± 15.4

Weight (kg)

62.7 ± 11.8

64.5 ± 11.6

63.8 ± 11.7

Height (cm)

163.6 ± 8.4

165.9 ± 8.2

164.9 ± 8.3

Male patients

459 (45.0%)

908 (44.5%)

1367 (44.7%)

With AT/AF

4 (0.4%)

7 (0.3%)

11 (0.4%)

EPS Only

15 (1.5%)

35 (1.7%)

50 (1.6%)

SVT

1001 (98.1%)

1998 (97.9%)

2999 (98.0%)

 Give upa

3 (0.3%)

5 (0.2%)

8 (0.3%)

 Ablation

998 (97.8%)

1993 (97.7%)

2991 (97.7%)

 Redo cases

5 (0.5%)

12 (0.6%)

17 (0.6%)

  1. Abbreviations: AT atrial tachycardia, AF atrial flutter, EPS electrophysiological study, ZF zero-fluoroscopy, CF conventional fluoroscopy, SVT supraventricular tachycardia
  2. asome patients refused to receive ablation owing to the possible risk after electrophysiology study